Glycan News and Research

RSS
Study provides insight into the structure of prion proteins responsible for diseases

Study provides insight into the structure of prion proteins responsible for diseases

Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease

Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease

Computational study of the structure and dynamics of glycosylated SARS-CoV-2

Computational study of the structure and dynamics of glycosylated SARS-CoV-2

New strategy for capturing interactions among glycans and protein activators in live cells

New strategy for capturing interactions among glycans and protein activators in live cells

SARS-CoV-2 may induce long-term autoimmune disorder due to self-glycan antibody production

SARS-CoV-2 may induce long-term autoimmune disorder due to self-glycan antibody production

Enzyme in the gut could provide a useful biomarker for intestinal diseases

Enzyme in the gut could provide a useful biomarker for intestinal diseases

Researchers identify a potential biomarker of aging

Researchers identify a potential biomarker of aging

New mutation in common flu subtype helps evade immune response

New mutation in common flu subtype helps evade immune response

Andrew Alliance online event - Wednesday, 1 April 2020 0900 to 1430 CET

Andrew Alliance online event - Wednesday, 1 April 2020 0900 to 1430 CET

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.